SCHEMBL13633811

SCHEMBL13633811

Cc1ccc2c(=O)c(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3Cl)n[nH]c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY12 Q9H244 1/20 0.42
MEN1 O00255 3/20 0.41
HTT P42858 3/20 0.41
KMT2A Q03164 3/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
RECQL P46063 1/20 0.41
FBP1 P09467 1/20 0.39
ITK Q08881 5/20 0.38
MAPT P10636 3/20 0.37
NTRK1 P04629 1/20 0.37
MAP2K7 O14733 1/20 0.37
ALDH1A1 P00352 1/20 0.36
LRRK2 Q5S007 1/20 0.36
CA12 O43570 2/20 0.35
CA9 Q16790 2/20 0.35
IMPDH2 P12268 1/20 0.35
KIT P10721 1/20 0.35
CA1 P00915 1/20 0.35
KDR P35968 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9922217 0.92 P2RY12 (0.45) P2RY12MEN1HTTKMT2ALMNA
SCHEMBL14088508 0.90 MEN1 (0.42) P2RY12MEN1HTTKMT2ALMNA
SCHEMBL9922639 0.89 P2RY12 (0.42) P2RY12MEN1HTTKMT2ALMNA
SCHEMBL14228352 0.86 CA12 (0.39) P2RY12ITKALDH1A1CA12CA9
SCHEMBL12161716 0.82 P2RY12 (0.44) P2RY12MEN1HTTKMT2ALMNA
SCHEMBL9922653 0.81 P2RY12 (0.46) P2RY12MEN1HTTKMT2ALMNA
SCHEMBL13633804 0.80 P2RY12 (0.43) P2RY12MEN1HTTKMT2ALMNA
SCHEMBL12161694 0.78 ROCK1 (0.44) P2RY12MEN1HTTKMT2ALMNA
SCHEMBL9922962 0.76 NAMPT (0.46) P2RY12MEN1HTTKMT2ALMNA
SCHEMBL13638644 0.76 FBP1 (0.42) MEN1HTTKMT2AFBP1ITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622474-B2 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-24 US disclosed